Cardiac Safety/TQT White Papers & Case Studies
-
Considerations When Selecting A CRO For Phase I Clinical Studies
6/17/2013
Phase I clinical trials are an integral step in the drug development process. Specific factors can influence the timelines and success of these studies. This white paper addresses the critical success factors for Phase I clinical studies and provides guidance on the appropriate capabilities, expertise and experience to evaluate as a sponsor selects a CRO.
-
Phase II Primary Insomnia Program In Need Of Full-Service CRO Management
12/6/2012
Clinilabs, a contract research organization (CRO), was selected by an international drug discovery and development company to provide full-service CRO management of a phase II primary insomnia program.
This website uses cookies to ensure you get the best experience on our website. Learn more